<DOC>
	<DOC>NCT00809536</DOC>
	<brief_summary>1. To estimate the effects of multiple doses of PD 0332334 on the elimination of a single dose of metformin from the body 2. To estimate the effects of multiple doses of metformin on the elimination of a single dose of PD 0332334 from the body 3. To evaluate the safety and tolerability when PD 0332334 and metformin are administered at the same time.</brief_summary>
	<brief_title>Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time</brief_title>
	<detailed_description>Detailed Description: Additional Study Purpose Details: To assess the pharmacokinetics of metformin and PD 0332334 with concurrent administration. On February 18th 2009, a decision to terminate further development for PD 0332334 was communicated to investigators in this study. The decision to terminate this study was not based on any safety concerns.</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Nonsmokers Male or female adults Current or history of significant medical illness Smokers Illicit drug use</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>metformin, PD 0332334, organic cation transporter, OCT2, pharmacokinetics</keyword>
</DOC>